Ultragenyx Pharma (RARE) Announces Positive Interim Data from KRN23 Phase 2 in TIO
Go back to Ultragenyx Pharma (RARE) Announces Positive Interim Data from KRN23 Phase 2 in TIOKirin Holdings Company, Limited Sponsored ADR (AMEX: KNBWY) | Delayed: 14.07 +0.14 (1.01%) | |||||
---|---|---|---|---|---|---|
Previous Close | $13.93 | 52 Week High | $18.64 | |||
Open | $14.40 | 52 Week Low | $12.59 | |||
Day High | $14.40 | P/E | N/A | |||
Day Low | $13.80 | EPS | $0.00 | |||
Volume | 19,504 |
ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 46.90 +0.08 (0.17%) | |||||
---|---|---|---|---|---|---|
Previous Close | $46.82 | 52 Week High | $117.12 | |||
Open | $46.91 | 52 Week Low | $46.52 | |||
Day High | $47.08 | P/E | N/A | |||
Day Low | $46.28 | EPS | $-1.97 | |||
Volume | 139,207 |